Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 16, 2024

BUY
$185.1 - $233.13 $3,331 - $4,196
18 Added 0.51%
3,535 $817,000
Q3 2023

Oct 13, 2023

BUY
$233.08 - $265.59 $32,398 - $36,917
139 Added 4.11%
3,517 $872,000
Q2 2023

Jul 07, 2023

BUY
$224.99 - $256.14 $98,095 - $111,677
436 Added 14.82%
3,378 $810,000
Q1 2023

May 10, 2023

BUY
$239.75 - $277.0 $89,666 - $103,598
374 Added 14.56%
2,942 $741,000
Q4 2022

Jan 13, 2023

BUY
$241.42 - $282.29 $22,452 - $26,252
93 Added 3.76%
2,568 $0
Q3 2022

Oct 13, 2022

BUY
$247.06 - $1507.4 $44,470 - $271,332
180 Added 7.84%
2,475 $639,000
Q2 2022

Jul 11, 2022

BUY
$237.11 - $299.66 $7,587 - $9,589
32 Added 1.41%
2,295 $582,000
Q1 2022

Apr 12, 2022

BUY
$257.27 - $315.76 $24,183 - $29,681
94 Added 4.33%
2,263 $664,000
Q4 2021

Feb 11, 2022

SELL
$292.08 - $329.01 $16,356 - $18,424
-56 Reduced 2.52%
2,169 $713,000
Q3 2021

Oct 06, 2021

BUY
$272.21 - $332.43 $31,848 - $38,894
117 Added 5.55%
2,225 $677,000
Q2 2021

Jul 12, 2021

BUY
$225.08 - $271.69 $23,633 - $28,527
105 Added 5.24%
2,108 $566,000
Q1 2021

May 17, 2021

SELL
$212.38 - $245.9 $12,530 - $14,508
-59 Reduced 2.86%
2,003 $451,000
Q4 2020

Feb 16, 2021

BUY
$212.5 - $245.46 $11,475 - $13,254
54 Added 2.69%
2,062 $458,000
Q3 2020

Oct 09, 2020

BUY
$177.16 - $215.33 $18,778 - $22,824
106 Added 5.57%
2,008 $432,000
Q2 2020

Jul 15, 2020

BUY
$128.7 - $176.83 $28,185 - $38,725
219 Added 13.01%
1,902 $336,000
Q1 2020

May 15, 2020

BUY
$121.39 - $169.05 $3,884 - $5,409
32 Added 1.94%
1,683 $233,000
Q4 2019

Jan 07, 2020

BUY
$133.47 - $153.48 $220,358 - $253,395
1,651 New
1,651 $253,000

Others Institutions Holding DHR

About DANAHER CORP


  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $177B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track Cooper Financial Group Portfolio

Follow Cooper Financial Group and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cooper Financial Group, based on Form 13F filings with the SEC.

News

Stay updated on Cooper Financial Group with notifications on news.